(Total Views: 403)
Posted On: 01/17/2020 9:59:50 AM
Post# of 72440
This is from May 30th 2018
BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed compound. The agreement includes an upfront payment, milestones and future royalties.
We still don't know what that undisclosed compound is. Can it be????
BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed compound. The agreement includes an upfront payment, milestones and future royalties.
We still don't know what that undisclosed compound is. Can it be????
(1)
(1)Scroll down for more posts ▼
